Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

Petelin Lara; Trainer Alison H.; Mitchell Gillian; Liew Danny; James Paul A.

首页> 外文期刊>Genetics in medicine >Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

【24h】

Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

机译：BRCA1 / 2突变载体中癌症风险管理策略的成本效益和比较效果：系统审查

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To review the evidence for the effectiveness and cost-effectiveness of cancer risk management interventions for BRCA carriers.

机译：目的：审查BRCA运营商癌症风险管理干预措施效力和成本效益的证据。

著录项

来源
《Genetics in medicine》 |2018年第10期|共12页
作者
Petelin Lara; Trainer Alison H.; Mitchell Gillian; Liew Danny; James Paul A.;
展开▼
作者单位

Peter MacCallum Canc Ctr Familial Canc Ctr Melbourne Vic Australia;

Peter MacCallum Canc Ctr Familial Canc Ctr Melbourne Vic Australia;

Peter MacCallum Canc Ctr Familial Canc Ctr Melbourne Vic Australia;

Monash Univ Sch Publ Hlth &

Prevent Med Melbourne Vic Australia;

Peter MacCallum Canc Ctr Familial Canc Ctr Melbourne Vic Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学遗传学;
关键词
BRCA; breast cancer; cancer risk management; cost-effectiveness; ovarian cancer;

机译：BRCA;乳腺癌;癌症风险管理;成本效益;卵巢癌;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review [J] . Petelin Lara, Trainer Alison H., Mitchell Gillian, Genetics in medicine . 2018,第10期

机译：BRCA1 / 2突变载体中癌症风险管理策略的成本效益和比较效果：系统审查
2. Risk of colorectal cancer associated with BRCA1 BRCA1 BRCA1 and/or BRCA2 BRCA2 BRCA2 mutation carriers: systematic review and meta‐analysis [J] . Cullinane C. M., Creavin B., OConnell E. P., The British Journal of Surgery . 2020,第8期

机译：与BRCA1 BRCA1 BRCA1和/或BRCA2 BRCA2 BRCA2突变载体相关的结直肠癌的风险：系统评价和荟萃分析
3. Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations|[quest]| A simulation of comparative cost-effectiveness [J] . G H de Bock, K M Vermeulen, L Jansen, British Journal of Cancer . 2013,第8期

机译：应该为患有BRCA1或BRCA2突变的女性提供哪种筛查策略| [quest] |相对成本效益的模拟
4. An Integrated Microfluidic Platform for Detecting BRCA1/BRCA2 Gene Mutation and Risk Assessment of Ovarian Cancer [C] . Yu-Hung Cheng, Chih-Hung Wang, Keng-Fu Hsu, International Conference on Solid-State Sensors, Actuators and Microsystems . 2021

机译：一种用于检测BRCA1 / BRCA2基因突变和卵巢癌风险评估的集成微流体平台
5. The Role of Reproductive Risk Factors in Hereditary Breast Cancer Within BRCA Mutation Carriers: Systematic Review and Meta-Analysis [D] . Springer, Tamara. 2021

机译：BRCA突变载体中生殖危险因素在遗传性乳腺癌中的作用：系统评价和荟萃分析
6. Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness [O] . G H de Bock, K M Vermeulen, L Jansen, 2013

机译：应为BRCA1或BRCA2突变的女性提供哪种筛查策略？相对成本效益的模拟
7. Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review [O] . Lara Petelin, Alison H Trainer, Gillian Mitchell, 2018

机译：BRCA1 / 2突变载体中癌症风险管理策略的成本效益和比较有效性：系统审查

Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review

摘要

著录项

相似文献

相关主题

期刊订阅